期刊文献+

冷沉淀中血管性血友病因子含量测定及意义 被引量:5

下载PDF
导出
摘要 目的通过检测冷沉淀中血管性血友病因子(vWF),并与新鲜冰冻血浆和冷上清比较,为评价冷沉淀质量和临床应用提供依据。方法应用酶联免疫吸附法检测无偿献血者新鲜冰冻血浆、冷沉淀和冷上清中vWF含量。结果新鲜冰冻血浆、冷沉淀和冷上清中vWF表达水平分别为(126.47±7.80)%、(268.50±19.51)%和(19.92±2.34)%。其中冷沉淀组明显高于新鲜冰冻血浆和冷上清。结论在严格控制制备条件下,冷沉淀中富含vWF,冷上清中残留的vWF很低,临床应用时,应该予以区别后选择使用。
作者 姚根宏
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第9期853-854,共2页 Chinese Journal of Blood Transfusion
  • 相关文献

参考文献7

  • 1Serrano K, Scammell K, Weiss S, et al. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Transfusion ,2010,50 (2) :344-353.
  • 2黄辉,苏寒,董震,张森林.富血小板血浆构建组织工程化细胞-膜片的结构和组成[J].医学研究生学报,2010,23(6):587-590. 被引量:7
  • 3Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Brit J Haematol,2010,149 (6) :834-843.
  • 4Yaser MH, Triulzi D J, Hassett AC, et al. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. Transfusion,2010,50( 5 ): 1014-1018.
  • 5Howman R,Barnes C,Curtin J,et al. The clinical efficacy and safety of the FVIII/VWF concentrate, BIOSTATE,in children with yon Willebrand disorder: a multi-centre retrospective review. Haemophilia,2011,17(3) :463-469.
  • 6Nieswandt B, Stoll G. The smaller, the better: VWF in stroke. Blood ,2010,115 ( 8 ): 1477-1478.
  • 7Bowyer AE, Shepherd F, Kitchen S, et al. A rapid automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Villebrand disease. Thromh Res,2011,127 (4) :341-344.

二级参考文献13

  • 1Endres M,Hutmacher DW,Salgado AJ,et al.Osteogenic induction of human bone marrow-derived mesenchymal pogenitor cells in novel synthetic polymer-hydrogel matrices[J].Tissue Eng,2003,9(4):689-702.
  • 2Zhou Y,Chen F,Ho ST,et al.Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts[J].Biomaterials,2007,28(5):814-824.
  • 3Shao XX,Hutmacher DW,Ho ST,et al.Evaluation of a hybrid scaffold /cell construct in repair of high-load-bearing osteochondral defects in rabbits[J].Biomaterials,2006,27(7):1071-1080.
  • 4Risbud M,Ringe J,Bhonde R,et al.In vitro expression of cartilage-specific markers by chondrocytes on a biocompatible hydrogel:Implications for engineered cartilage tissue[J].Cell Transplant,2001,10(8):755-760.
  • 5Pouliot R,Larouche D,Auger FA,et al.Reconstructed human skin produced in vitro and grafted on athymic mice[J].Transplantation,2002,73(11):1751-1757.
  • 6L'Heureux N,Paquet S,Labbe R,et al.A completely biological tissue-engineered human blood vessel[J].FASEB J,1998,12(1):47-56.
  • 7Nishida K,Yamato M,Hayashida Y,et al.Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium[J].N Engl J Med,2004,351(12):1187-1196.
  • 8Marx RE.Platelet-rich plasma:evidence to support its use[J].J Oral Maxillofac Surg,2004,62(4):489-496.
  • 9Frechette JP,Martineau I,Gagnon G.Platelet-rich plasma:growth factor content and roles in wound healing[J].J Dent Res,2005,84(5):434-439.
  • 10Freymiller EG,Agbaloo TL.Platelet-rich plasma:ready or not?[J] J Oral Maxillofac Surg,2004,62(4):484-488.

共引文献6

同被引文献55

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部